The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Cooper Glenn L Md since year 2005.
The trader's CIK number is 1046351.
At the time of the last reporting, Cooper Glenn L Md was the Director of Repligen Corp .
(stock ticker symbol RGEN).
See this page for all insider trading activities at Repligen Corp .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2012-11-30||CNDO||Fortress Biotech, Inc.||Buy||3,811||4.02||15,320|
|2012-06-22||CNDO||Fortress Biotech, Inc.||Buy||10,000||5.30||52,970|
|2009-02-23||IDEV||Indevus Pharmaceuticals Inc||Option Ex||279,898||.00||0|
|2006-01-09||IDEV||Indevus Pharmaceuticals Inc||Buy||10,000||5.85||58,500|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cooper Glenn L Md (Director of Repligen Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.